PFE Latest Headlines

4 stocks to watch on Tuesday: DASH, SOFI, BA, and PFE

at seekingalpha.com (Tue, 27-Oct 9:08 AM)

Pfizer (PFE) Receives a Hold from Citi

at www.tipranks.com (Tue, 27-Oct 7:31 AM)

Pfizer posts late-stage trial win for multiple myeloma drug Elrexfio in an earlier line setting

at seekingalpha.com (Tue, 27-Oct 7:25 AM)

Pfizer Talzenna/Xtandi combo approved for earlier prostate cancer setting

at seekingalpha.com (Mon, 26-Oct 6:06 PM)

Pfizer (PFE) Gets a Buy from Scotiabank

at www.tipranks.com (Mon, 26-Oct 10:37 AM)

Celcuity says Revtorpyk boosts progression-free survival in breast cancer

at seekingalpha.com (Mon, 26-Oct 10:37 AM)

Nuvectis Reports Complete Brain Tumor Responses as Big Pharma Pays Billions for Cancer Drugs (NASDAQ: NVCT)

at www.tipranks.com (Mon, 26-Oct 9:40 AM)

Analysts Conflicted on These Healthcare Names: Revolution Medicines (RVMD), Pfizer (PFE) and Summit Therapeutics (SMMT)

at www.tipranks.com (Mon, 26-Oct 6:30 AM)

Pfizer (PFE) Gets a Buy from Jefferies

at www.tipranks.com (Mon, 26-Oct 4:35 AM)

Pfizer (PFE) Lung Cancer Drug Shows Survival Benefit Despite Trial Failure

at www.tipranks.com (Sun, 25-Oct 7:20 AM)

Pfizer sees strong response for pediatric pneumonia vaccine in mid-stage trial

at seekingalpha.com (Sat, 24-Oct 1:44 PM)

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Offers Upside, According to Wall Street?

at www.tipranks.com (Fri, 23-Oct 4:14 AM)

Pfizer’s LITFULO Shows Significant Repigmentation for Nonsegmental Vitiligo: Phase 3 Trials Deliver Landmark Results

Market Chameleon (Thu, 30-Jul 9:43 AM)